Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06780709

Impact of a Structured Wellness Behavioral Intervention on Quality of Life in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Led by Icahn School of Medicine at Mount Sinai · Updated on 2025-04-17

20

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating whether a structured wellness program can improve the quality of life for adults living with Neuromyelitis Optica Spectrum Disorder (NMOSD). This pilot randomized controlled trial will compare immediate versus delayed start of a multi-modal wellness program tailored to NMOSD patients, involving physical therapists, dietitians, social workers, nurse practitioners, and cognitive therapists. The study aims to assess quality of life using the MS-Quality of Life-54 tool as the primary measurement. Participants will be randomly assigned to either begin the wellness program immediately or after a 6-month delay. The program includes comprehensive evaluations by a dietician, social worker, physical therapist, nurse practitioner, and behavioral neuropsychologist. Follow-up sessions will monitor progress and challenges. After the initial 6-month period, participants may join a one-year extension study with additional wellness interventions and bi-monthly behavioral counseling. Throughout the study, participants will complete surveys and objective assessments at baseline, 12 weeks, 6 months, 12 months, and 18 months to evaluate quality of life, vision, mobility, exercise habits, diet adherence, and motor and vision function. These measures help researchers understand the program's impact and its sustainability over time. The total study duration for those in the extension phase can be up to 18 months.

CONDITIONS

Brief Title

Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years or older with NMOSD diagnosed by 2015 clinical criteria
  • All levels of disability (EDSS scores) are eligible
  • Patients on any treatment type or no treatment are eligible
Not Eligible

You will not qualify if you...

  • Under 18 years of age
  • Unable to provide voluntary consent
  • Unable to participate in study assessments or currently enrolled in another randomized controlled trial or wellness intervention
  • Relapse within 30 days of randomization
  • Medical restrictions on physical activity
  • Starting stimulants or dalfampridine between enrollment and randomization

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Behavioral Treatment

Duration - 6 months

Participants receive wellness program services and behavioral interventions including dietary, physical therapy, social work, nurse practitioner evaluations, and behavioral counseling to implement recommendations.

Initial evaluation at baseline and follow-up evaluations during the 6 months

Follow-up and Assessments

Duration - Up to 6 months

Participants complete assessments to evaluate quality of life, mobility, vision, exercise, diet, and motor and vision function at 12 weeks and 6 months.

Assessments at 12 weeks and 6 months

Extension Study Behavioral Treatment

Duration - 12 months

Participants may continue in a one-year extension study with one additional wellness intervention and bimonthly behavioral counseling sessions to support sustainability of the wellness program.

One wellness intervention and bimonthly behavioral counseling sessions during the year

Extension Study Follow-up and Assessments

Duration - 6 months

Participants complete assessments at 12 months and 18 months to assess the long-term sustainability of the wellness program.

Assessments at 12 months and 18 months

Trial Site Locations

Total: 1 location

1

Corinne Goldsmith Dickinson Center for MS at Mount Sinai

New York, New York, United States, 10029

Actively Recruiting

Loading map...

Research Team

S

Susan Filomena

S

Savannah Steer

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

A Phase 1 Dose Escalation and Safety Study of HBI0101 CAR-T ...

Systemic Sclerosis (SSc)

Actively Recruiting

1 location

Safety and Pharmacodynamics of QH103 Cell Injection in Patie...

Multiple Sclerosis (MS)

Actively Recruiting

1 location

Observational Study of Ultomiris (Ravulizumab) Safety in Pre...

Ultomiris-exposed Pregnant/ Postpartum

Actively Recruiting

7 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here